Profile: Elizabeth Coyle
Assistant Dean of Assessment
141 Science & Research Bldg. 2, Room 114
Houston, TX 77204-5000
ASHP Accredited Pharmacy Practice Residency, University of Nebraska, Medical Center, Omaha, NE
ASHP Accredited Critical Care Specialty Residency, University of Kentucky, Medical Center, Lexington, KY
Research Fellow, Infectious Diseases Pharmacotherapy, Wayne State, University College of Pharmacy & Allied Health, Detroit, MI
Coyle EA, Kuper K, and Garey K. Wyeth PGY2 Infectious Diseases Residency Grant. Society of Infectious Diseases Pharmacists (SIDP) ($40,000)
Coyle EA, Lewis RE, Rolston KV, and Prince RA. Influence of Daptomycin Compared to that of Penicillin, Clindamycin and Linezolid on Streptococcal Pyrogenic Exotoxin A & B (SPE A & B) Release and Antibacterial Activity. Cubist Pharmaceuticals ($20,969)
Coyle EA, Lewis RE, Rolston KV, and Prince RA. Influence of Linezolid Compared to Clindamycin and Vancomycin on Staphylococcal Toxic Shock Toxin-1 (TSST-1) Release. Pharmacia grant ($30,288)
Lewis RE, Coyle EA, Prince RA. Antibacterial activity and biofilm-resistance of Staphylococcus spp. after treatment with linezolid or vancomycin in an in vitro model of catheter-related bloodstream infection. Pharmacia grant ($37,432)
Lewis RE, Coyle EA, Prince RA. Pharmacodynamics of varying doses of Levofloxacin against Pseudomonas aeruginosa. Ortho-McNeil Pharmaceuticals ($25,000)
Coyle EA, Hershberger E, Zervos M. A 10 year multi-center evaluation of quinolone usage and susceptibility trends. Pfizer educational grant ($10,000)
- Fellow, College of Critical Care Medicine, 2009
- University of Houston Faculty Teaching Excellence Award Finalist, 2009
- University of Houston College of Pharmacy Faculty Teaching Excellence Award, 2008
- Society of Critical Care Medicine Presidential Citation, 2007
- Society of Critical Care Medicine Presidential Citation, 2006
- PLS Outstanding Faculty Leadership Award, 2004-05
- University of Houston College of Pharmacy Faculty Preceptor of the Year, 2003
Rolston KV, Kapadia M, Tarrand J, Coyle E, Prince RA. Spectrum of gram-positive bacteraemia and in vitro activities of daptomycin, linezolid and vancomycin against organisms isolated from cancer patients. Int J Antimicrob Agents. 2013 Jun;41(6):516-20. doi: 10.1016/j.ijantimicag.2013.01.014. Epub 2013 Mar 6.
Hatfield CL, Coyle EA. Factors that influence student completion of course and faculty evaluations. Am J Pharm Educ. 2013 Mar 12;77(2):27. doi: 10.5688/ajpe77227.
Kuper KM, Coyle EA, Wanger A. Antifungal susceptibility testing: a primer for clinicians. Pharmacotherapy. 2012 Dec;32(12):1112-22. doi: 10.1002/phar.1146. Epub 2012 Nov 16. Review.
Hogan HL, Hachem RY, Neuhauser M, Raad II, Coyle E. Clinical experience of linezolid in bone marrow transplantation patients. J Pharm Pract. 2010 Aug;23(4):352-7.
Mihu CN, Rhomberg PR, Jones RN, Coyle E, Prince RA, Rolston KV. Escherichia coli resistance to quinolones at a comprehensive cancer center. Diagn Microbiol Infect Dis. 2010 Jul;67(3):266-9.
Coyle EA. Invasive candidiasis and the utility of antifungal susceptibility testing in the ICU. J Pharm Pract. 2010 Feb;23(1):33-7.
Birtcher KK, Corbett SM, Pass SE, Coyle EA, Yeh RF, Tipton J, Garey KW; Academic Pharmacy Symposium. Symposium on roles of and cooperation between academic- and practice-based pharmacy clinicians. Am J Health Syst Pharm. 2010 Feb 1;67(3):231-8.
Yeh RF, Kuper KM, Coyle EA, Garey KW, Ikwuagwu JO, Maclayton DO, Mohr JF, Musick WL, Pass SE, Rios E, Tam VH; Houston Infectious Disease Network. Significant publications on infectious diseases pharmacotherapy in 2007. Am J Health Syst Pharm. 2008 Nov 15;65(22):e72-9.
Tam VH, Kabbara S, Vo G, Schilling AN, Coyle EA. Comparative pharmacodynamics of gentamicin against Staphylococcus aureus and Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2006 Aug;50(8):2626-31.
Tam VH, Schilling AN, Neshat S, Poole K, Melnick DA, Coyle EA. Optimization of meropenem minimum concentration/MIC ratio to suppress in vitro resistance of Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2005 Dec;49(12):4920-7.
Tam VH, Schilling AN, Melnick DA, Coyle EA. Comparison of beta-lactams in counter-selecting resistance of Pseudomonas aeruginosa. Diagn Microbiol Infect Dis. 2005 Jun;52(2):145-51.
Wiederhold NP, Coyle EA, Raad II, Prince RA, Lewis RE. Antibacterial activity of linezolid and vancomycin in an in vitro pharmacodynamic model of gram-positive catheter-related bacteraemia. J Antimicrob Chemother. 2005 May;55(5):792-5.
Coyle EA and Prince RA. Urinary Tract Infections and Prostatitis. Pharmacotherapy, A Pathophysiologic Approach, Eighth Edition, 2011
Coyle EA. Pyelonephritis Case. Pharmacotherapy Casebook: A Patient-Focused Approach. Publication in Progress
Coyle EA and Prince RA. Urinary Tract Infections and Prostatitis. Pharmacotherapy, A Pathophysiologic Approach, Seventh Edition, 2008
Coyle EA and Prince RA. Urinary Tract Infections and Prostatitis. Chapter 44. Primary Care Textbook, First Edition, 2008
Contributor, The SCCM Injectable Drug Reference. Second Edition, 2006
Coyle EA and Akins RA. Clindamycin. Antimicrobials and Vaccinations, Volume II, 2005
Coyle EA and Prince RA. Urinary Tract Infections and Prostatitis. Pharmacotherapy, A Pathophysiologic Approach, Sixth Edition, 2005
Coyle EA, Johnson TN, Riccobono D, et. al. Evaluation of Appropriate Empiric Antibiotic Selection for Bloodstream Infections in a Cancer Center. The 37th SCCM Critical Care Conference. Honolulu, Hawaii. February 2008. Abstract #961.
Johnson TN, Coyle EA, Riccobono D, et. al. Timing of Empiric Antibiotics in Bacteremic Patients Admitted to a Cancer Hospital Emergency Center. The 37th SCCM Critical Care Conference. Honolulu, Hawaii. February 2008. Abstract #962.
Riccobono D, Coyle EA, Johnson TN, et al. Stratification of Infecting Organisms, Susceptibilities, and Antibiotic Selection Based on Admitting Service in a Cancer Center. The ACCP Annual Conference, San Francisco, CA. October 2007. Abstract #324.
Kapadia M, Coyle EA, Prince RA, and Rolston KVI. Declining In Vitro Activity of Vancomycin against Staphylococcus aureus Isolates from Cancer Patients. The 45th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, D.C., December 2005. Abstract # E-807.
Kapadia M, Coyle EA,Rolston KVI, et. al. In Vitro Activity of Daptomycin Compared to Vancomycin and Linezolid against Staphylococcus aureus Isolates in a Cancer Center. The 45th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, D.C., December 2005. Abstract # E-1745.
Tam VH, Kabbara S, Schilling AN, et. al. (#5). Pharmacodynamics of Gentamicin against Staphylococcus aureus and Pseudomonas aeruginosa. (December 2005) The 45th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, D.C., Abstract # A-1825.
- Society of Critical Care Medicine
- Society of Infectious Disease Pharmacists
- American Society of Microbiology
- American College of Clinical Pharmacy
- ACCP Critical Care Practice Network
- ACCP Infectious Disease Practice Network
- American Society of Health-System Pharmacists
- American Association of Colleges of Pharmacy
- Texas Society of Health-System Pharmacists
- Texas Chapter of Society of Critical Care Medicine
- Journal Reviewer: Antimicrobrial Agents and Chemotherapy, 2009 - present
- Journal Reviewer: Pharmacotherapy, 2001 - present
- Journal Reviewer: Annals of Pharmacotherapy, 2000 - present